Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03504163 |
Title | Pembrolizumab (MK-3475) as First-line Therapy for Carcinoma in Situ (Tis) Non-Muscle-Invasive Bladder Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Memorial Sloan Kettering Cancer Center |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Memorial Sloan Kettering Basking Ridge (All Protocol Activities) | RECRUITING | Basking Ridge | New Jersey | 10065 | United States | Details |
Memorial Sloan Kettering Monmouth (All Protocol Activities) | RECRUITING | Middletown | New Jersey | 07748 | United States | Details |
Memorial Sloan Kettering Bergen (All protocol activities) | RECRUITING | Montvale | New Jersey | 07645 | United States | Details |
Memorial Sloan Kettering Commack (All protocol activities) | RECRUITING | Commack | New York | 11725 | United States | Details |
Memorial Sloan Kettering West Harrison (All Protocol Activities) | RECRUITING | Harrison | New York | 10604 | United States | Details |
Memorial Sloan Kettering Cancer Center (All Protocol Activities) | RECRUITING | New York | New York | 10065 | United States | Details |
Memorial Sloan Kettering Nassau (All Protocol Activities) | RECRUITING | Uniondale | New York | 11553 | United States | Details |